| 13.97 | -0.08 / -0.57% |
Data as of 3:59pm ET | Day’s Change |
| 13.97 | |
Volume: -- |
| Volcano Product Launch at EuroPCR - Analyst Blog May 21 / Zacks.com | Alleged Patent Infringement by BSX - Analyst Blog May 17 / Zacks.com |
| Natus Medical Beats on Both Top and Bottom Lines May 20 / MotleyFool.com | Neutral Rating Restated for Cepheid - Analyst Blog May 13 / Zacks.com |
| Previous close | 14.05 |
| Today’s open | 14.01 |
| Day’s range | 13.82 - 14.21 |
| Volume | 172,794 |
| Average volume (3 months) | 127,331 |
| Market cap | $426.9M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +34.19% |
| Earnings growth (next 5 years) | +18.50% |
| Revenue growth (last year) | +25.63% |
| P/E ratio | 107.5 |
| Price/Sales | 1.11 |
| Price/Book | 1.57 |
| Today’s change | Today’s % change | |
|---|---|---|
| CSIICardiovascular Syste... | +1.29 | +7.28% |
| ATRIAtrion Corp | +0.96 | +0.45% |
| MMSIMerit Medical System... | +0.02 | +0.20% |
| SQNMSequenom Inc | +0.17 | +4.35% |
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $0.18 |
| Annual revenue (last year) | $292.3M |
| Annual profit (last year) | $3.9M |
| Net profit margin | 1.24% |
Sector Health Technology |
Industry Medical Specialties |
President & Chief Operating Officer John T. Buhler |
Chief Executive Officer & Director James B. Hawkins, MBA |
Corporate headquarters San Carlos, California |
